bioRxiv Science⌕ Search

Biology subjects

Bespalov, M. M.

Publications and source records attributed to Bespalov, M. M..

3 recordsLinked to original sources

Maturation of Neuronal Activity in Caudalized Human Brain Organoids

Human brain organoids are an emerging tool to study functional neuronal networks in health and disease. A critical challenge is the engineering of brain organoids with defined regional identity and developmental stage. Here we describe a protocol for generating hindbrain-like organoids from human pluripotent stem cells. We first generated a stable pool of caudalized stem cells that expressed hindbrain identity transcription factors and differentiated into tissue containing neurons and astrocytes. After maturation, caudalized brain organoids presented synaptically connected networks consisting of glutamate-, GABA-, and serotoninergic postmitotic neurons. These mature neurons displayed electric properties and dendritic trees resembling medulla oblongata neurons. They fired spontaneous and evoked repetitive action potentials, released serotonin and displayed excitatory and inhibitory synaptic currents, functionally resembling the activity patterns observed in normal human fetal brain. Reminiscent of infected human fetal brain, infection with Zika virus hampered organoid development, while the treatment with anticonvulsant drugs - carbamazepine and valproic acid - reduced organoid growth. Neuronal maturation also occurred in the grafted organoids in vivo. In conclusion, our approach enables efficient derivation of caudalized neuronal stem cells that differentiate into mature and functional neurons in organoids with hindbrain identity following human developmental trajectory. The organoids provide excellent model to study congenital abnormalities in brain development and for drug testing.

neuroscience↗

GDNF receptor agonist supports dopamine neurons in vitro and protects their function in animal model of Parkinson's disease.

Motor symptoms of Parkinsons disease (PD) are caused by degeneration and progressive loss of nigrostriatal dopamine neurons. Currently no cure for this disease is available. Existing drugs alleviate PD symptoms, but fail to halt neurodegeneration. Glial cell line-derived neurotrophic factor (GDNF) is able to protect and repair dopamine neurons in vitro and in animal models of PD, but its clinical use is complicated by pharmacokinetic properties. In the present study we demonstrate the ability of a small molecule agonist of GDNF receptor RET to support the survival of cultured dopamine neurons only when they express GDNF receptors. In addition, BT13 activates intracellular signaling cascades in vivo, stimulates release of dopamine and protect the function of dopaminergic neurons in a 6-hydroxydopamine (6-OHDA) rat model of PD. In contrast to GDNF, BT13 is able to penetrate through the blood-brain-barrier. Thus, BT13 serves as an excellent tool compound for the development of novel disease-modifying treatments against PD.

neuroscience↗

Human pluripotent reprogramming with CRISPR activators

CRISPR/Cas9 based gene activation (CRISPRa) is an attractive tool for cellular reprogramming applications due to its high multiplexing capacity and direct targeting of endogenous loci. Here we present the reprogramming of primary human skin fibroblasts into induced pluripotent stem cells (iPSC) using CRISPRa, targeting endogenous OCT4, SOX2, KLF4, MYC and LIN28A promoters. The basal reprogramming efficiency can be improved by an order of magnitude by additionally targeting a conserved Alu-motif, enriched near genes involved in embryo genome activation (EEA-motif). This effect is mediated in part by more efficient activation of NANOG and REX1. These data constitute a proof of principle that somatic cells can be reprogrammed into iPSC using only CRISPRa. Furthermore, the results unravel previously uncharacterized involvement of EEA-motif-associated mechanisms in cellular reprogramming.

cell biology↗